Researchers led by a team at Optum examined claims data on nearly 5.3 million person-years from 2016-19 across 20 different measurements and found that patients in accountable care models were 9% ...
In their suit, Shanon and William Schmidtknect allege that Optum operates as part of a prescription drug "oligopoly" that controls nearly 80 percent of all prescriptions in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback